Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Peking University Cancer Hospital & Institute
University of Washington
University of Washington
University of Washington
Centre Georges Francois Leclerc
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)